Last reviewed · How we verify

NCT06797856

Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer

Completed Last updated 23 July 2025
What this trial tests

trial testing Refractive Error in Measurement of Refractive Error in 46 participants. Completed in 9 July 2025.

Timeline
17 February 2025
Primary endpoint
9 July 2025
9 July 2025

Quick facts

Lead sponsorJohnson & Johnson Surgical Vision, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment46
Start date17 February 2025
Primary completion9 July 2025
Estimated completion9 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johnson & Johnson Surgical Vision, Inc. — full company profile →

Who can join

40 and older, any sex, with Measurement of Refractive Error. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, single-site, non-interventional, technician masked, randomized (instrument and examiner testing sequences), controlled, bilateral, parallel-group study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Johnson & Johnson Surgical Vision, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06797856.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing